Loading...
Please wait, while we are loading the content...
Similar Documents
Measuring the symptom burden associated with the treatment of chronic myeloid leukemia
| Content Provider | Scilit |
|---|---|
| Author | Williams, Loretta A. Gonzalez, Araceli G. Garcia Ault, Patricia Mendoza, Tito R. Sailors, Mary L. Williams, Janet L. Huang, Furong Nazha, Aziz Kantarjian, Hagop M. Cleeland, Charles S. Cortes, Jorge |
| Copyright Year | 2013 |
| Description | Key Points The MD Anderson Symptom Inventory for CML can be used to collect patient-reported symptoms for research and clinical practice. Thirty percent of patients in chronic-phase CML and on TKIs experience moderate symptoms that interfere with daily functioning. |
| Related Links | http://www.bloodjournal.org/content/bloodjournal/122/5/641.full.pdf |
| Ending Page | 647 |
| Page Count | 7 |
| Starting Page | 641 |
| DOI | 10.1182/blood-2013-01-477687 |
| Journal | Blood |
| Issue Number | 5 |
| Volume Number | 122 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2013-08-01 |
| Access Restriction | Open |
| Subject Keyword | Hematology Treatment Leukemia Cml Functioning Myeloid Tkis Percent Anderson Interfere Journal: Blood (Vol- 84, Issue- 5) |
| Content Type | Text |
| Resource Type | Article |